Beijing Strong Biotechnologies, Inc. (300406.SZ) obtained a medical device registration certificate.
Jiuphar Biotech (stock code: 300406.SZ) issued an announcement on November 13, 2024, stating that the company has received a notification from the Beijing Drug...
Beijing Strong Biotechnologies, Inc. (300406.SZ) announced that on November 13, 2024, the company received the "Medical Device Registration Certificate" issued by the Beijing Municipal Drug Administration. The product name is Interleukin-6 assay kit (magnetic particles chemiluminescent immunoassay), which is used for the quantitative determination of Interleukin-6 (IL-6) in human serum or plasma.
The acquisition of the above-mentioned product medical device registration certificate enriches the company's product categories, enhances the company's core competitiveness, and has a positive impact on the company's future development.
Related Articles

HK Stock Market Move | ZYLOXTB(02190) rose more than 5% midday, with several innovative products expected to be approved one after another. The company's profit potential is expected to continue to increase.

Sinolink: Three major gears of commercial space are accelerating. It is recommended to focus on areas such as rocket recovery and 3D printing.

CICC: First coverage of Contemporary Amperex Technology (03750) with a "outperform" rating and a target price of 580 Hong Kong dollars.
HK Stock Market Move | ZYLOXTB(02190) rose more than 5% midday, with several innovative products expected to be approved one after another. The company's profit potential is expected to continue to increase.

Sinolink: Three major gears of commercial space are accelerating. It is recommended to focus on areas such as rocket recovery and 3D printing.

CICC: First coverage of Contemporary Amperex Technology (03750) with a "outperform" rating and a target price of 580 Hong Kong dollars.

RECOMMEND

Not Just “Power Shortages,” Delays Will Become The Key Theme For U.S. Data Centers In 2026
26/12/2025

Hang Seng Index Rises 33% This Year, Best Five‑Year Performance; Multiple Institutions Forecast Breakthrough Above 30,000 Next Year
26/12/2025

Gold Rally Has Further To Run, JPMorgan Bullish: Prices Could Reach USD 5,055 By Year‑End 2026
26/12/2025


